Clinical trials recruiting for Embolic Stroke of Undetermined Source
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Empagliflozin 10 MG | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Pennsylvania | 1 |
Top cities
Self-screener
Recruiting trials
- AI-Based Prediction of Atrial Fibrillation in ESUS Patients With ICM
- Atrial Fibrillation Detection Using MEMO Patch in Patients With Stroke of Unknown Cause
- EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source
- Echocardiographic Predictors of Atrial Fibrillation
- Left Atrial Strain and Cryptogenic Stroke
- Prospective Registry of Elderly ESUS With PFO
Related conditions
Trials recruiting for Embolic Stroke of Undetermined Source often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Embolic Stroke of Undetermined Source trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.